La cadena de opciones muestra datos clave de las opciones de acciones de Processa Pharma a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Processa Pharma..

Processa Pharma (NASDAQ:PCSA) Bolsa, Cadena de Opciones

Processa Pharma

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals Inc

The study found that twice-yearly lenacapavir for pre-exposure prophylaxis (PrEP) was highly efficacious at reducing HIV infections, reducing them by 96% compared to background HIV incidence.&nbsp;
Twice-yearly lenacapavir for PrEP also demonstrated superiority to once-daily Truvada&#xAE; (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg; F/TDF) for PrEP and was generally well-tolerated, with no significant or new safety concerns identified.&nbsp;
&nbsp;

News

GILD

Gilead Says NEJM Published Full Results From Pivotal Phase 3 Purpose 2 Trial Evaluating Twice-yearly Lenacapavir

AREB

American Rebel Receives Delinquency Notification Letter From Nasdaq

PMEC

Primech Holdings Gets Nasdaq Minimum Bid Price Requirement Extension Until May 12, 2025, To Regain Compliance

CELU

Celularity Receives Notification From Nasdaq About Non-Compliance With Continued Listing Requirements

Retailers are expecting a record-breaking Black Friday to Cyber Monday shopping period as cash-strapped consumers are expected to shop early in the holiday season for sales <a href="https://www.benzinga.com/news/retail-sales/24/11/42220200/black-friday-discounts-too-good-to-be-true-survey-shows-only-42-of-sales-are-authentic">promotions and savings.&nbsp;</a>
What To Know: Management consultancy firm Bain &amp; Company <a href="https://www.bain.com/insights/black-friday-2024-sales-forecast-snap-chart/">forecasts</a> U.S. retail sales during the Black Friday to Cyber Monday period will reach $75 billion for the first time ever, growing by about 5% year-over-year. The firm sees about 8% of total holiday sales will come during this period, the highest share since 2019, underscoring the importance of the key shopping period for retailers.&nbsp;
"The holiday shopping season has been reshaped in recent years, where consumers are making purchases earlier, driven by a stream of discounts that has allowed shoppers to manage their budgets in different ways," says Vivek Pandya, lead analyst, Adobe Digital Insights.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/retail-sales/24/11/42170721/thanksgiving-dinner-gobbles-up-19-more-cash-this-year-many-holiday-hosts-already-regret-their-decision">Thanksgiving Dinner Gobbles Up 19% More Cash This Year, Many Holiday Hosts &#8216;Already Regret Their Decision&#8217;</a>
Online Shopping: Adobe Digital Insights <a href="https://news.adobe.com/news/2024/09/092524-adi-holiday-forecast">expects</a> Cyber Week (the 5-day period including Thanksgiving, Black Friday and Cyber Monday) online sales of $40.6 billion, up 7% over last year and adding up to 16.9% of the overall holiday season sales.&nbsp;
Adobe sees Cyber Monday as the biggest shopping day of the year, driving a record $13.2 billion in sales, an increase of 6.1% from 2023.&nbsp;
In-store Shopping: In-store shopping still remains an important part of Black Friday for many consumers. According to<a href="https://www.linkedin.com/redir/redirect?url=http%3A%2F%2FPlacer%2Eai&amp;urlhash=w5Z_&amp;trk=article-ssr-frontend-pulse_little-text-block"> Placer.ai</a> analytics, Black Friday 2023 saw a 300% increase in mall visits compared to the first three weeks of November. Superstores also saw an 81% rise, demonstrating demand across shopping formats.&nbsp;
Most Wanted Items: Consumers are expected to gobble up Cyber Week deals on electronics from retailers like Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) on hot items like Beats Studio Pro Wireless Noise Cancelling Headphones at more than 60% off its regular price.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/retail-sales/24/11/42220200/black-friday-discounts-too-good-to-be-true-survey-shows-only-42-of-sales-are-authentic">Black Friday Discounts Too Good To Be True? Survey Shows Only 42% Of Sales Are Authentic</a>
Placer.ai expects beauty and personal care items to be another hot item with discounts on gift sets from retailers like Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) drawing shoppers online and in stores.&nbsp;
Sporting goods and outdoor equipment will see record-high discounts averaging 20%, according to Abode Digital Insights, with retailers like Dicks Sporting Goods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) benefiting from the increased spending on experiences and activities.&nbsp;
When To Shop: Adobe Digital Insights says Thanksgiving Day will be the best day to shop for toys, appliances, furniture and sporting goods, while Black Friday will offer the deepest discounts for TVs. The Saturday after Thanksgiving will have the best deals for computers and Cyber Monday will be the best day to shop for electronics and apparel, the two biggest categories in e-commerce by revenue share. 
Read More: • <a href="https://www.benzinga.com/24/11/42194570/starbucks-employee-systems-down-after-software-provider-suffers-ransomware-attack">Starbucks&#8217; Employee Systems Down After Software Provider Suffers Ransomware Attack</a>
Photo: gonghuimin468 from Pixabay

Retail Sales

General

ULTA

Black Friday, Cyber Monday Shopping Set To Break Sales Records

XELB

XCEL BRANDS Receives Delinquency Notification Letter From Nasdaq

Shares of Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) are trading lower on Wednesday but they may have found support. The company posted earnings that were <a href="https://www.benzinga.com/news/offerings/24/11/42202548/autodesk-stock-slides-on-q3-earnings-key-details-from-quarter">slightly better than estimates</a> but investors are concerned about decreasing margins.
Our team of traders and technical analysts has made it our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
Operating margin is the percent of profit a company has on a dollar of sales after all costs are considered. In Q3 of last year, Autodesk had an operating margin of 24%. This means that for every dollar of sales, the company kept 24 cents.
But this year, the margin has dropped to 22%. This means they are now only keeping 22 cents. This may not sound like a significant drop, but it shows that the company is becoming less efficient. This may be a bearish sign for the longer-term and some investors are selling.
It isn't a coincidence that the shares found support around the $293 level.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="532" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-1024x532.png" alt="Autodesk" class="wp-image-668317" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-1024x532.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-768x399.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-1536x798.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2.png 1567w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42216384/feds-favorite-inflation-gauge-heats-up-as-predicted-personal-incomes-soar-december-interest-rate-cut-in-doubt">Fed&#8217;s Favorite Inflation Gauge Heats Up As Predicted, Personal Incomes Soar</a>
As you can see on the chart, this level was resistance in October. Many of the investors and traders who sold at this resistance thought they made a good decision when the price dropped soon after.
But in early November the resistance broke and the stock gapped higher. When this happened, some of those who sold came to regret their decision to do so. A number of them decided to buy their shares back.
But they would only do so if they could buy them at the same price they were sold for.
As a result, now that the stock has dropped back to their selling prices they are placing buy orders. The large concentration of these orders has formed support at the price that had been resistance.
Sometimes stocks rally after they drop to resistance.
This happens because some of the buyers become nervous. They know that the sellers are going to go to whoever is willing to pay the highest price. They are afraid that they will be outbid by other buyers.
So, they increase their bid prices. Other nervous buyers see this and do the same thing. It could result in a snowball effect or bidding war that pushes the price up.
Levels that had been resistance can become support. Stocks tend to rally after reaching support. Shares of Autodesk may be about to move higher.
Price Action: Autodesk closed Wednesday at $290.64 per share, down 8.6%. 
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42197276/anthony-scaramucci-trump-win-is-the-greatest-political-comeback-in-us-history-crypto-surge-following-it-was-3-years-overdue">Anthony Scaramucci: Trump Win Is &#8216;The Greatest Political Comeback In US History,&#8217; Crypto Surge Following It Was 3 Years Overdue</a>

Technicals

Trading Ideas

ADSK

Stock Of The Day: Autodesk Beats Earnings As Shares Find Support At This Level

Canada has started preparing for potential retaliatory tariffs on U.S. goods following President-elect Donald Trump's recent threats to impose sweeping <a href="https://www.benzinga.com/topic/canada">duties on Canadian imports.</a> 
A senior Canadian government official told <a href="https://apnews.com/article/canada-trump-tariffs-trudeau-c741393c2f7c7545e9714839cfbbda45">AP News</a> Wednesday that discussions are underway to target certain U.S. items if Trump follows through on his proposed 25% tariff, although no final decision has been made.
This move comes as Trump renews his hardline stance on trade, calling for punitive tariffs to address what he described as the flow of drugs and migrants across both the northern and southern borders. 
Canada has faced a similar situation in the past, such as in 2018 when it imposed billions of dollars in retaliatory duties on U.S. goods after the Trump administration hiked tariffs on Canadian steel and aluminum.
<h3 class="wp-block-heading">Canadian Dollar Poised For Further Declines</h3>
Wall Street analysts expect additional downside in the Canadian dollar – as tracked by the Invesco CurrencyShares Canadian Dollar Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXC#NYSE">FXC</a>) – if the tariff threats materialize.
Robert Kavcic, senior economist at BMO Economics, highlighted Canada's vulnerability as a &#8220;small, open economy&#8221; heavily reliant on U.S. trade. 
&#8220;The U.S. market accounts for roughly 75% of Canadian goods exports, which in total comprise about 25% of Canadian GDP,&#8221; Kavcic wrote in a note.
"In general, we'd expect the Canadian dollar to see the biggest and most immediate market impact, extending the weakness seen in recent months. In this event, we see room for further depreciation from recent levels above 1.41 against the dollar."
Shaun Osborne, chief forex strategist at Scotiabank, also expressed skepticism about Canada's ability to quickly address the incoming administration&#8217;s concerns. 
Osborne explained that Trump's newly appointed &#8220;border czar,&#8221; Tom Homan, has already labeled the northern border as &#8220;an extreme national security issue,&#8221; which could complicate negotiations.
&#8220;More CAD losses seem inevitable unless the Canadian government can muster a response that satisfies the incoming administration quickly, however. That may not be easy,&#8221; Osborne warned. 
He continued, &#8220;The risk of 25% tariffs remains just that at the moment, but the longer the threat lingers and the closer we get to the inauguration, the weaker the CAD may trade."
According to data from the U.S. Census Bureau, U.S. imports from Canada reached $481 billion in 2023, while Canadian imports of U.S. goods amounted to $354 billion during the same period.
In terms of products, Canada's top export to the United States was crude oil and other fuels, totaling approximately $120 billion, followed by vehicles at $58 billion.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42219612/usmexico-trade-tensions-escalate-as-mexican-peso-hits-august-2022-lows-why-is-auto-industry-most-at-risk">US–Mexico Trade Tensions Escalate As Mexican Peso Hits August 2022 Lows: Why Is Auto Industry Most At Risk?</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Government

Macro Economic Events

Regulations

Currency ETFs

Politics

Forex

Global

Economics

Markets

Analyst Ratings

ETFs

Canada Prepares Retaliatory Tariffs After Trump Threats: Analysts Warn Of Further Loonie Weakness

Mexican President Claudia Sheinbaum responded to U.S. President-elect Donald Trump in a letter published Tuesday, addressing the issue of the <a href="https://www.benzinga.com/markets/cannabis/24/03/37445551/overdose-crisis-worsens-the-rise-of-fentanyl-smoking-leads-to-even-more-deaths-than-shooting-her">fentanyl crisis</a> and broader drug-related challenges.
Her message emphasized cooperation over confrontation — whereas Trump has a <a href="https://www.benzinga.com/news/24/10/41563454/trumps-escalating-threats-to-rivals-100-and-counting">penchant for the latter</a>.
&#8220;Neither threats nor tariffs will solve the migration or the drug abuse phenomenon in the US,&#8221; Sheinbaum <a href="https://x.com/Claudiashein/status/1861558804652999130">said</a>, calling for collaborative solutions to mitigate the escalating drug crisis.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Migración y consumo de fentanilo no se atenderán con amenazas ni aranceles. México avanza con resultados en acciones integrales; la cooperación y el entendimiento son necesarios. El diálogo es el camino. <a href="https://t.co/mwXkhUCwbL">pic.twitter.com/mwXkhUCwbL</a>
&mdash; Claudia Sheinbaum Pardo (@Claudiashein) <a href="https://twitter.com/Claudiashein/status/1861558804652999130?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Sheinbaum To Trump: Fentanyl &#8216;Is An Issue In Your Country&#8217; </h3>
&#8220;For humanitarian reasons, we have consistently expressed Mexico&#8217;s commitment to preventing the continuation of the <a href="https://www.benzinga.com/general/health-care/24/11/42146502/us-overdose-deaths-decline-as-fentanyl-potency-weakens-harm-reduction-expands">fentanyl epidemic</a> in the United States, which, moreover, is an issue of consumption and public health in your country,&#8221; Sheinbaum says in the letter, which she read during her usual morning conferences. 
Sheinbaum detailed Mexico's recent measures, including enforcement actions by the armed forces and prosecutors. According to the data she shared, in 2024 alone, authorities seized large quantities of &#8220;various drugs&#8221;, confiscated over 10,340 firearms, and arrested more than 15,640 individuals for drug-related violence.
Furthermore, she noted Mexico&#8217;s legislative progress toward stricter penalties.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Not Us</h3>
Sheinbaum called attention to the illicit flow of chemical precursors from Asia, which enter North America through Canada, the U.S., and Mexico. 
She stressed that addressing this issue requires international collaboration: &#8220;It is publicly known that these precursors are smuggled into North America. This makes global cooperation imperative.&#8221;
The president juxtaposed the flow of drugs with the southbound<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42166673/drug-cartels-use-tether-and-bitcoin-to-launder-millions-court-documents-reveal"> illegal trafficking</a> of <a href="https://www.benzinga.com/topic/guns">firearms</a> from the U.S. into Mexico. 
She cited stark statistics: 70% of illegal weapons seized in Mexico originate in the U.S., fueling violence. 
&#8220;The synthetic drugs are not consumed by us, and the weapons are not produced here. Yet, we bear the brunt of the deaths caused by organized crime in response to the demand for drugs in your country.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42069004/how-trumps-election-could-revolutionize-cannabis-and-cryptocurrency-ceo-says">How Trump&#8217;s Election Could Revolutionize Cannabis And Cryptocurrency, CEO Says</a>
<h3 class="wp-block-heading">&#8216;Reciprocal Understanding And Cooperation&#8217;</h3>
Sheinbaum rejected the efficacy of punitive tariffs in addressing these challenges. 
Instead, she urged for &#8220;reciprocal understanding and cooperation&#8221; between the two nations. 
She noted that mutual economic ties, especially in industries like automotive manufacturing, <a href="https://www.benzinga.com/news/global/24/11/42198583/will-trump-lead-us-into-trade-war-with-mexico-president-claudia-sheinbaum-rebukes-threats">would suffer</a> under an antagonistic approach, leading to inflation and job losses on both sides of the border, and posed that both Mexico and the U.S. should work together on a mobility program instead of reinforcing the borders. 
&#8220;I am convinced that North America's economic strength lies in preserving our commercial partnership. Dialogue is the best path toward understanding, peace, and prosperity for our nations,&#8221; she added.
<ul>
<li>Read Next:<a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42202496/goldman-sachs-expects-major-selloffs-in-canadian-dollar-mexican-peso-says-trump-tariffs-threaten-usmca-agreement"> Goldman Sachs Expects Major Selloffs In Canadian Dollar, Mexican Peso, Says Trump Tariffs Threaten USMCA Agreement</a></li>
</ul>
Translations in this article were made by Rolando García
Cover: Shutterstock.

Cannabis

Mexico President Claudia Sheinbaum To Trump: 'Neither Threats Nor Tariffs' Will Solve Your Fentanyl Crisis

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares have been treading water for the better part of the past month. The company reported earnings at the end of October. Here&#8217;s a look at what <a href="https://www.benzinga.com/general/social-media/24/11/42177636/meta-heads-to-trial-over-instagram-whatsapp-acquisitions">you need to know</a>.
What To Know: Meta shares have struggled to move higher since the company reported third-quarter financial results last month. Although Meta <a href="https://www.benzinga.com/news/earnings/24/10/41637326/meta-platforms-q3-earnings-revenue-beat-eps-beat-daily-actives-up-5-strong-momentum-in-ai">beat analyst estimates</a> on the top and bottom lines as revenue jumped 19% and daily actives climbed 5%, the stock faced selling pressure due to spending concerns. 
Meta raised its full-year 2024 capital expenditures&nbsp;outlook by $1 billion and said it continues to expect operating losses to &#8220;increase meaningfully&#8221; year-over-year&nbsp;for Reality Labs.
It&#8217;s worth noting that insiders have been selling Meta shares in recent months. CEO Mark Zuckerberg, CFO Susan Li and COO Javier Olivan all sold shares in November under trading plans, with Olivan most recently selling shares on Monday, according to Benzinga <a href="https://www.benzinga.com/quote/META/insider-trades">data</a>.
On a positive note, <a href="https://www.axios.com/2024/11/26/exclusive-threads-adds-35m-new-signups-this-month">Axios</a> reported Wednesday that Meta&#8217;s Threads has added 35 million new users on the platform since Nov. 1. Micro-blogging startup Bluesky has seen users flock to the platform since Election Day, suggesting users are leaving X because of Elon Musk&#8217;s political views. Meta also appears to be a beneficiary.
Check This Out: <a href="https://www.benzinga.com/24/11/42193222/orange-taps-openai-meta-to-create-ai-that-speaks-african-languages">Meta, OpenAI, Orange Join Forces To Build AI Models For African Languages</a>
On the earnings call last month, Zuckerberg said Threads had over 275 million monthly active users. That number appears to be growing rapidly with Axios reporting that the app has seen more than one million daily sign-ups for three months straight.
Meta aims to capitalize on the momentum. Zuckerberg on Monday said Threads is testing a new feature that will allow users to choose what they see when they open the app. Previously, Threads directed users to a default feed, but users can now choose to only see posts from accounts they follow.
Meta is also set to <a href="https://www.benzinga.com/general/social-media/24/11/42177636/meta-heads-to-trial-over-instagram-whatsapp-acquisitions">head to trial in April</a> after Judge James Boasberg rejected Meta&#8217;s attempted dismissal of the case and set a court date earlier this week. The Facebook parent company will face U.S. Federal Trade Commission allegations that it acquired Instagram and WhatsApp&nbsp;to stifle competition in the social media space. 
META Price Action: Meta shares closed Wednesday down 0.76% at $569.20, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

What's Up With Meta Stock Lately?

The cryptocurrency <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">XRP Token</a> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) from Ripple has soared in price over the last week, with optimism coming from an XRP exchange-traded fund and news that Ripple will invest in a newly rebranded <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42220218/ripple-to-invest-in-rebranded-xrp-exchange-traded-product-by-bitwise">Physical XRP ETP.</a>
While Ripple has hit new 52-week highs, the cryptocurrency remains down from all-time highs.
What Happened: Asset manager WisdomTree recently filed to establish a trust that could lead to the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42170669/wisdomtree-files-for-xrp-etf-trust-report">launch of an XRP ETF.</a>
This move follows others like Bitwise who have already filed to launch similar ETFs. On Wednesday, Ripple announced it would invest in the new rebranded Bitwise Physical XRP ETP.
&#8220;Global demand for exposure to the crypto asset class has exploded in 2024,&#8221; Ripple CEO Brad Garlinghouse said in a&nbsp;<a href="https://www.globenewswire.com/news-release/2024/11/27/2987978/0/en/Bitwise-Rebrands-XRP-ETP-Ripple-To-Invest-in-Product.html" target="_blank" rel="noreferrer noopener">statement</a>. &#8220;XRP is at the forefront of this momentum, standing out as a cornerstone for those seeking access to assets that are resilient and have real-world utility.&#8221;
Bitwise CEO Hunter Horsley said XRP's utility and reliability are among the reasons investors are excited about XRP.
&#8220;XRP and the XRP Ledger are among the most familiar and trusted blockchains in crypto," Horsley said.
With Bitcoin and Ethereum ETFs already approved, cryptocurrency experts see ETFs based on other top 10 cryptos by market capitalization like Solana, Dogecoin and XRP as the&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011875/solana-ripple-litecoin-etfs-may-be-on-the-table-under-trump-administration-industry-experts-think" target="_blank" rel="noreferrer noopener">next to be approved.</a>
The XRP token has gone through many wild swings over the years, with a case brought on by the SEC alleging XRP to be a security, sending the price and interest in the cryptocurrency down. A landmark court ruling that said XRP was not a security helped bring the cryptocurrency&#8217;s price back up.
While XRP has risen in value in recent months, the cryptocurrency remains down from all-time highs.
Read Also: <a href="https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today">If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here&#8217;s How Much You&#8217;d Have Today</a>
Investing $100 in XRP Today: XRP trades at $1.51 at the time of writing, up 9% over the last 24 hours.
A $100 investment today could purchase 66.2252 XRP.
XRP hit an all-time high of $3.84 on June 4, 2018.
If XRP returns to its 2018 all-time high of $3.84, the $100 investment would be worth $254.30. This represents a potential gain of 154.3%.
There is no guarantee that the XRP Token will return to its all-time highs.
The hypothetical investment shows that a small investment could gain over time if the cryptocurrency market returns to its high mark.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41908812/if-you-invested-100-in-dogecoin-when-the-meme-coin-launched-heres-how-much-youd-have-today">If You Invested $100 In Dogecoin When The Meme Coin Launched, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$XRP

Here's How Much $100 Invested In XRP Token Today Will Be Worth If Crypto Returns To All-Time Highs

Offerings

Cyngn Files For Offering Of Up To 3.06M Units, Up To 3.06M Pre-Funded Units

APLT

Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption Times

CTHR

Charles & Colvard Receives Nasdaq Notice About Non-Compliance Of Listing Rule 5250(c)(1)

Velocity Financial Files For Stock Shelf Of Up To $100M

MRKR

Marker Therapeutics Sales Agreement Prospectus Covers Offering Of Up To $11.4M Of Common Stock That May Be Issued From Time To Time

Converium Capital and Erez Asset Management will vote their shares in favor of all of the Board's director nominees at the 2025 Annual Meeting of Stockholders. Under the Cooperation Agreement, Converium Capital and Erez Asset Management have agreed to customary standstill, voting and other provisions.&nbsp;

Management

Franklin Street Properties Enters Cooperation Agreement With Shareholders Converium Capital And Erez Asset Management; Adds Bruce Schanzer To Board

Marker Therapeutics Files For Mixed Shelf Of Up To $300M

Urban Outfitters, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares traded higher on Wednesday following the release of the company&#8217;s third-quarter earnings report, which exceeded expectations. Here&#8217;s <a href="https://www.benzinga.com/quote/URBN/news">what you need to know.</a>
What To Know: Urban Outfitters reported third-quarter earnings per share of $1.10, beating estimates of 89 cents. Revenue came in at $1.36 billion, up 6.3% year-over-year and ahead of the consensus estimate of $1.32 billion.
The company posted net income of $102.9 million for the quarter, compared to $83 million a year ago. Retail net sales rose 3.2%, with comparable retail sales up 1.5%. Anthropologie and Free People brands reported comparable sales growth of 5.8% and 5.3%, respectively, while Urban Outfitters brand sales fell 8.9%.
See More: <a href="https://www.benzinga.com/24/11/42221225/these-analysts-increase-their-forecasts-on-urban-outfitters-after-q3-results">These Analysts Increase Their Forecasts On Urban Outfitters After Q3 Results</a>
Nuuly, the company's subscription rental service, grew sales by 48.4%, supported by a 51% increase in active subscribers. Wholesale revenue increased 17.4%, driven by a 20.3% rise in Free People wholesale sales, partially offset by declining Urban Outfitters wholesale revenue.
Gross profit for the quarter rose 9.4% to $497.3 million, with a 105-basis-point improvement in gross margin due to higher merchandise markups and fewer markdowns at Urban Outfitters. Operating expenses increased 6.7%, reflecting higher marketing and store payroll costs.
&#8220;These results were driven by outperformance across all three business segments – Retail, Subscription and Wholesale. Additionally, we&#8217;re optimistic about the outlook for Holiday demand and believe total comparable sales could be similar to our third quarter results,&#8221; said Richard Hayne, CEO of Urban Outfitters.
The company ended the quarter with $182.5 million in cash, $340.4 million in marketable securities and a 10% inventory increase, largely due to early holiday merchandise shipments and higher sales expectations.
Following the print, several analysts raised price targets, which appears to have helped push shares higher on Wednesday.
<ul>
<li>Citigroup analyst Paul Lejuez upgraded Urban Outfitters from Neutral to Buy and raised the price target from $42 to $59.</li>
</ul>
<ul>
<li>Telsey Advisory Group analyst Dana Telsey maintained a Market Perform and raised the price target from $44 to $46.</li>
</ul>
<ul>
<li>BofA Securities analyst Lorraine Hutchinson maintained a Buy and raised the price target from $46 to $53.</li>
</ul>
<ul>
<li>Barclays analyst Adrienne Yih maintained an Overweight and raised the price target from $43 to $51.</li>
</ul>
<ul>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight and raised the price target from $40 to $48.</li>
</ul>
URBN Price Action: Urban Outfitters shares closed Wednesday up 18.3% at $47.49, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="521" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-1024x521.png" alt="" class="wp-image-668199" style="width:474px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-1024x521.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27152029/URBN.png 1465w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/travel/24/11/42223099/boeing-faces-heat-from-frustrated-emirates-over-52-billion-aircraft-delays">Boeing Faces Heat From &#8216;Frustrated&#8217; Emirates Over $52 Billion Aircraft Delays</a></li>
</ul>
Image Via Shutterstock.

Earnings

Price Target

URBN

Urban Outfitters Stock Surged Wednesday: What Happened?

GYRE

Gyre Therapeutics Entered Into Open Market Sale Agreement, May Offer & Sell Shares Of Common Stock Of Up To $50M From Time To Time

FDA approves Processa Phase 2 study for NGC-Cap, stock rallies 46%

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Processa Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/pcsa-stock-quote/">PCSA</a>) stock is rising higher on Tuesday after the company <a href="https://finance.yahoo.com/news/processa-pharmaceuticals-announces-fda-clearance-120000203.html">posted an update</a> from the Food and Drug Administration (FDA).



The FDA has cleared Processa Pharmaceuticals for its Phase 2 clinical trial Next Generation Capecitabine (NGC-Cap). This is the company&rsquo;s lead product candidate and is designed to treat patients with advanced or metastatic breast cancer.



With this approval, Processa Pharmaceuticals is able to move forward with a clinical trial of NGC-Cap. The company says that it expect to start enrolling patients in this study this quarter.



David Young, president of research and development at Processa Pharmaceuticals, said this about NGC-Cap.




&ldquo;We previously demonstrated in our Phase 1b study that NGC-Cap is more potent than monotherapy capecitabine, providing up to 5-10 times more 5-fluorouracil exposure to cancer cells. This greater exposure resulted in a greater efficacy, with a safety profile better or similar to existing monotherapy with capecitabine.&rdquo;




<h2>PCSA Stock Movement Today</h2>



With all of this comes heavy trading of PCSA stock today. That has more than 51 million shares changing hands as of this writing. This is a massive surge compared to the company&rsquo;s daily average trading volume of about 90,000 shares.



PCSA stock is up 29.4% as of Tuesday morning.



Investors seeking out even more of the most recent stock market stories are going to want to stick around!



We are offering up insight into all of the hottest stock market news that investors need to know about on Tuesday! A few examples include what&rsquo;s happening with shares of Tesla&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>), Delta&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/dal-stock-quote/">DAL</a>) and SoFi&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sofi-stock-quote/">SOFI</a>) stock today. All of that news is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/tsla-stock-drops-as-tesla-recalls-1-8-million-evs-over-hood-issue/">TSLA Stock Drops as Tesla Recalls 1.8 Million EVs Over Hood Issue</a></li>



<li><a href="https://investorplace.com/2024/07/dal-stock-delta-wants-crowdstrike-to-pay-up-for-flight-delays-caused-by-outage/">DAL Stock: Delta Wants CrowdStrike to Pay Up for Flight Delays Caused by Outage</a></li>



<li><a href="https://investorplace.com/2024/07/sofi-stock-sofi-just-raised-its-profit-guidance-again-whats-going-on/">SOFI Stock: SoFi Just Raised Its Profit Guidance Again. What&rsquo;s Going On?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-processa-pharmaceuticals-pcsa-stock-up-29-today/">Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
2U&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/twou-stock-quote/">TWOU</a>) stock is still rallying higher as a bankruptcy filing has introduced an immense amount of volatility to the online education platform company&rsquo;s shares.



Today&rsquo;s movement has TWOU stock rallying 15.5% as of Tuesday morning. That comes with more than 31 million shares changing hands. For the record, its daily average trading volume is about 2.5 million shares.



The rally today <a href="https://investorplace.com/2024/07/2u-twou-stock-pops-more-than-100-despite-bankruptcy-filing/">follows a surge yesterday</a> that saw the stock jump as more than 100% higher during normal trading hours. It is worth noting that these rallies come after the stock suffered a roughly 60% drop when news of its bankruptcy broke.



<h2>What&rsquo;s Next for 2U Stock?</h2>



2U is using this bankruptcy to <a href="https://investorplace.com/2024/07/twou-stock-alert-2u-plunges-on-ch-11-bankruptcy-filing/">restructure its debt</a> via deals with lenders. This has the company continuing operations throughout the process. It expects to exit bankruptcy by the end of September.



It&rsquo;s also unclear how this bankruptcy filing will affect TWOU stock. While the company is only using it for restructuring, it could cause problems for its listing on the Nasdaq Exchange.



Also, all of this volatility makes TWOU stock a bit of a risky investment. Traders will want to keep that in mind before taking a stake in the company.



Investors will want to stick around for more of the most recent stock market news!



We have all of the hottest stock market stories that traders need to know about on Tuesday! That includes warnings of a potential market crash, why Processa Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/pcsa-stock-quote/">PCSA</a>) stock is up today and more. All of this info is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/a-potential-stock-market-crash-trigger-looms-on-july-31/">A Potential Stock Market Crash Trigger Looms on July 31</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-processa-pharmaceuticals-pcsa-stock-up-29-today/">Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/tsla-stock-drops-as-tesla-recalls-1-8-million-evs-over-hood-issue/">TSLA Stock Drops as Tesla Recalls 1.8 Million EVs Over Hood Issue</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/2u-twou-stock-continues-to-surge-in-bankruptcy-rally/">2U (TWOU) Stock Continues to Surge in Bankruptcy Rally</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

2U (TWOU) Stock Continues to Surge in Bankruptcy Rally

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Processa Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/pcsa-stock-quote/">PCSA</a>) just reported results for the second quarter of 2024.<ul><li>Processa Pharma reported earnings per share of -$1.01. This was below the analyst estimate for EPS of -98 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/pcsa-stock-earnings-processa-pharma-for-q2-of-2024/">PCSA Stock Earnings: Processa Pharma Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PCSA Stock Earnings: Processa Pharma Misses EPS for Q2 2024

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Processa Pharmaceuticals (PCSA – Research Report), H...

Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Healthequity (HQY)

Processa Pharmaceuticals reports GAAP EPS of -$1.01

Processa stock rallies 35% post-market on Phase 2 study update

Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Processa Pharmaceuticals (PCSA – Research Report), retaining the price target o...

Buy Rating Affirmed for Processa Pharmaceuticals Amidst Promising Phase 2 Trial for NGC-Cap

Processa Pharmaceuticals GAAP EPS of -$1.03

Processa Pharmaceuticals, Inc. ( ($PCSA) ) has released its Q3 earnings. Here is a breakdown of the information Processa Pharmaceuticals, Inc. pres...

Processa Pharmaceuticals Reports Q3 2024 Financial Results

PCSA

PSNL

SOFI

TSLA

TWOU

Press Releases

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer

Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer

Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri

Processa Pharmaceuticals Provides Product Pipeline and Financial Update

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

Comments

Processa Pharma

Processa Pharma (PCSA) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL